VIR
VIR
NASDAQ · Biotechnology

Vir Biotechnology Inc

$9.16
-0.14 (-1.51%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +85.4% upside
Low Target $13.41
Average Target $16.98
High Target $22.24
Current Price $9.16
Current
$9.16
Target
$16.98
$13.41 $16.98 avg $22.24
Scenario Analysis
Bear Case
$13.41
46.4%
Low target
Base Case
$16.98
+85.4%
Avg target
Bull Case
$22.24
+142.8%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$11.66
-21.4% from high
52-Week Low
$4.16
+120.5% from low
Target vs 52W High
$16.98
+45.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -39.1%